Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male Subjects
Clinical trial NCT01967589 · COMPLETED
Trial details
- NCT number
- NCT01967589
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-05-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.